Literature DB >> 2597177

Inhibition of rat liver and duodenum soluble catechol-O-methyltransferase by a tight-binding inhibitor OR-462.

E Schultz1, E Nissinen.   

Abstract

The inhibition kinetics of rat liver and duodenum soluble catechol-O-methyltransferase (COMT) with a disubstituted catechol OR-462 was studied. After preincubation of the enzyme and inhibitor in the presence of magnesium and S-adenyosylmethionine, an inhibition about thirty times greater than that without preincubation was observed. Reversible tight-binding inhibition was demonstrated with Ki values of 0.7 nM and 1.0 nM for liver and duodenum enzyme, respectively. Km values of 53.4 microM and 56.9 microM for substrate 3,4-dihydroxybenzoic acid and 23.0 microM and 17.5 microM for S-adenosylmethionine were calculated for liver and duodenum enzyme, respectively. A catalytic number of 24/min for liver soluble COMT was calculated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2597177     DOI: 10.1016/0006-2952(89)90673-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  11 in total

1.  Large-scale QM/MM free energy simulations of enzyme catalysis reveal the influence of charge transfer.

Authors:  Heather J Kulik
Journal:  Phys Chem Chem Phys       Date:  2018-08-08       Impact factor: 3.676

2.  Methyltransferases do not work by compression, cratic, or desolvation effects, but by electrostatic preorganization.

Authors:  Jeronimo Lameira; Ram Prasad Bora; Zhen T Chu; Arieh Warshel
Journal:  Proteins       Date:  2015-01-07

Review 3.  Clinical pharmacology, therapeutic use and potential of COMT inhibitors in Parkinson's disease.

Authors:  S Kaakkola
Journal:  Drugs       Date:  2000-06       Impact factor: 9.546

Review 4.  Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.

Authors:  José A Apud; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 5.  Role of dopamine and other stimuli of mucosal bicarbonate secretion in duodenal protection.

Authors:  G Flemström; B Säfsten
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

6.  Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone.

Authors:  E Nissinen; I B Lindén; E Schultz; P Pohto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

7.  How Large Should the QM Region Be in QM/MM Calculations? The Case of Catechol O-Methyltransferase.

Authors:  Heather J Kulik; Jianyu Zhang; Judith P Klinman; Todd J Martínez
Journal:  J Phys Chem B       Date:  2016-10-28       Impact factor: 2.991

8.  Structural and biochemical characterization of Rv0187, an O-methyltransferase from Mycobacterium tuberculosis.

Authors:  Sanghyun Lee; Jihoon Kang; Jungwook Kim
Journal:  Sci Rep       Date:  2019-05-30       Impact factor: 4.379

9.  Mapping the conformational space accessible to catechol-O-methyltransferase.

Authors:  Andreas Ehler; Jörg Benz; Daniel Schlatter; Markus G Rudolph
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-07-25

10.  Computational Investigation of the Interplay of Substrate Positioning and Reactivity in Catechol O-Methyltransferase.

Authors:  Niladri Patra; Efthymios I Ioannidis; Heather J Kulik
Journal:  PLoS One       Date:  2016-08-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.